CoChat

Cerebrovascular mortality in patients with pituitary adenoma

Brada, M., Ashley, S., Ford, D., Traish, D., Burchell, L., Rajan, B. · 2002 · Clinical Endocrinology
Cited by 150

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Objective To assess cerebrovascular mortality in a UK cohort of patients with pituitary adenoma known to have increased incidence of cerebrovascular accidents (CVA). Methods A total of 334 patients treated at the Royal Marsden Hospital (RMH) between 1962 and 1986 with surgery and postoperative radiotherapy were followed up via the NHS Central Register (NHSCR) to identify deaths and emigrations. The causes of death were assessed by NHSCR‐based death certificates and coded according to the 9th revision of ICD. Follow‐up was censored at age 85, on emigration or cancellation of NHSCR. Thirteen patients could not be traced. A total of 4982 person‐years was accumulated in the cohort. Expected numbers of deaths were computed from the national age‐, sex‐ and period‐specific mortality rates for England and Wales. Results In the pituitary adenoma cohort, 128 deaths were observed compared to 80·9 expected [relative risk (RR) of death 1·58 (95% CI: 1·32–1·90)]. There were 33 cerebrovascular deaths compared with 8·04 expected (RR 4·11, 95% CI 2·84–5·75). Three deaths were from subarachnoid haemorrhage compared to 0·54 expected (RR 5·51, 95% CI 1·14–16·09). There was an increased cerebrovascular mortality in women (RR 6·93, 95% CI 4·29–10·60) compared to men (RR 2·4, 95% CI 1·24–4·20; P = 0·002) and in patients having debulking surgery (RR 5·19, 95% CI 3·50–7·42) compared to biopsy/no surgery (RR 1·33, 95% CI 0·27–3·88; P = 0·02). The RR in patients with nonsecretory tumours was 3·65 (95% CI 2·26–5·58), compared with 5·23 (95% CI 2·25–10·30) in secretory tumours (P = 0·4). The effect of age at radiotherapy was not significant (P = 0·4). Conclusion Patients with pituitary adenoma treated with surgery and radiotherapy have an increased risk of cerebrovascular mortality compared to the general population, which mirrors the increased incidence of CVA. The possible risk factors include hypopituitarism, radiotherapy and extent of surgery but none are at present proven causes. The evaluation of new treatment strategies should not only assess intermediate end‐points of tumour and endocrine control but should concentrate on long‐term survival with particular emphasis on CVA incidence and mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2002.01570.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 150

Metadata

Authors
Brada, M., Ashley, S., Ford, D., Traish, D., Burchell, L., & Rajan, B.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2002-12
Volume
57
Issue
6
Pages
713-717
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2156492466
Cited by
150
References
3
FWCI
1.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrovascular mortality in patients with pituitary adenoma. https://app.cochat.ai/papers/10.1046/j.1365-2265.2002.01570.x
The paper
Brada, M., Ashley, S., Ford, D., Traish, D., Burchell, L., & Rajan, B. (2002). Cerebrovascular mortality in patients with pituitary adenoma. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2002.01570.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.